Pakistan, China sign $1.4 billion pharma, vaccine and equipment manufacturing agreements
Final day saw 42 deals worth about $850 million as more than 250 Chinese companies explored healthcare, medical equipment and industrial projects

Pakistan and China signed investment and business agreements worth approximately $1.4 billion during a two-day conference in Islamabad, with commitments covering pharmaceuticals, vaccine production, medical equipment, healthcare technology and industrial manufacturing.
The Pakistan-China Business Conference, held on July 17 and 18, brought together more than 250 Chinese companies and a large number of Pakistani businesses for business-to-business meetings on investment, trade, technology transfer and industrial cooperation.
Participants signed 42 agreements worth around $850 million on the final day. The conference concluded with overall investment commitments reaching approximately $1.4 billion.
Major agreements included plans to manufacture pharmaceutical products, vaccines and medical equipment locally. The proposed projects are expected to expand domestic production, reduce import dependence, introduce new technologies and create employment.
Companies from both countries also discussed joint ventures, supply-chain improvements and long-term industrial partnerships aimed at increasing local manufacturing capacity and exports.
The pharmaceutical and healthcare industries accounted for a significant portion of the proposed investments. The agreements include the establishment of production facilities for medicines, vaccines and medical devices, with potential access to regional and international export markets.
Industry representatives said cooperation with Chinese companies could improve product quality and strengthen research, development and advanced manufacturing capabilities in Pakistan’s healthcare sector.
Federation of Pakistan Chambers of Commerce and Industry President Atif Ikram Sheikh described the agreements as an important development for bilateral economic cooperation. He said investments in pharmaceuticals, vaccine manufacturing and other industries would support technology transfer, employment creation, exports and industrial growth.
Rawalpindi Chamber of Commerce and Industry President Usman Shaukat said the commitments reflected growing confidence among Chinese investors in Pakistan’s business environment.
He said stronger cooperation in pharmaceuticals, vaccines and advanced manufacturing would support local industries, generate jobs and create export opportunities.
The conference also highlighted the increasing role of private-sector partnerships in Pakistan-China economic relations, with businesses expecting the agreements to develop into investment projects over the coming months.
Comments
No comments yet. Be the first to join the discussion!







